RCKT - Financial Reports List - Rocket Pharmaceuticals, Inc. - IntrinsicAlpha

Rocket Pharmaceuticals, Inc. RCKT

Healthcare - Biotechnology - NASDAQ - US

$ 6.97

13.3 %

$ 743 M

Market Cap

-2.63

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-1.12%	0.92%
Annual Report	FY	10-K	2024-12-31	0.00%	-5.35%	-5.22%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-7.79%	-6.11%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-6.00%	-7.21%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-12.94%	-8.33%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	7.31%	8.40%
Annual Report	FY	10-K	2023-12-31	0.00%	-11.95%	-15.74%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-8.55%	-11.87%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-20.34%	-26.83%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-26.60%	-46.12%

1